Oncolytics Biotech
ONCY
#9621
Rank
โ‚ฌ88.95 M
Marketcap
0,75ย โ‚ฌ
Share price
2.50%
Change (1 day)
-26.37%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ11.67 Million

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are โ‚ฌ11.67 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ9.68 M-0.41%
2024-12-31โ‚ฌ9.72 M26.73%
2023-12-31โ‚ฌ7.67 M3.17%
2022-12-31โ‚ฌ7.44 M9.84%
2021-12-31โ‚ฌ6.77 M10.75%
2020-12-31โ‚ฌ6.11 M-54.72%
2019-12-31โ‚ฌ13.5 M142.76%
2018-12-31โ‚ฌ5.56 M-14.91%
2017-12-31โ‚ฌ6.53 M127.23%
2016-12-31โ‚ฌ2.87 M61.16%
2015-12-31โ‚ฌ1.78 M-25.28%
2014-12-31โ‚ฌ2.38 M-41.52%
2013-12-31โ‚ฌ4.08 M-26.25%
2012-12-31โ‚ฌ5.54 M12.95%
2011-12-31โ‚ฌ4.9 M160.96%
2010-12-31โ‚ฌ1.87 M-33.29%
2009-12-31โ‚ฌ2.81 M5.73%
2008-12-31โ‚ฌ2.66 M36.59%
2007-12-31โ‚ฌ1.95 M8.47%
2006-12-31โ‚ฌ1.79 M34.31%
2005-12-31โ‚ฌ1.33 M98.67%
2004-12-31โ‚ฌ0.67 M6.34%
2003-12-31โ‚ฌ0.63 M-26.03%
2002-12-31โ‚ฌ0.85 M-61.37%
2001-12-31โ‚ฌ2.21 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
โ‚ฌ75.01 B 642,274.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ58.31 B 499,290.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
โ‚ฌ0.16 B 1,278.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
โ‚ฌ20.92 M 79.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ27.94 B 239,219.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
โ‚ฌ63.6 M 444.64%๐Ÿ‡บ๐Ÿ‡ธ USA